Navigation Links
NVISION Laser Eye Centers First in the Nation to Offer Avellino-GENE Detection System Test to Protect Patients from Blindness
Date:5/14/2013

MENLO PARK, Calif., May 14, 2013 /PRNewswire/ -- Avellino Lab USA, developer of the only genetic test available worldwide for Avellino Corneal Dystrophy (ACD), today announced that California-based NVISION Laser Eye Centers is the first provider in the United States to offer patients the Avellino-GENE Detection System (AGDS™) Test that makes LASIK safer. Prior to undergoing refractive surgery such as LASIK, the AGDS Test detects, with 100 percent accuracy, the ACD genetic mutation in which carriers are at an extremely high risk of experiencing eventual blindness as a result of vision-correction refractive surgery. NVISION Laser Eye Centers now offer Avellino Lab USA's AGDS Test at 10 of its 17 locations throughout California.

(Logo: http://photos.prnewswire.com/prnh/20130514/SF12152LOGO)

The AGDS Test is the world's first genetic test to detect ACD, a disease that causes cloudiness, specifically grey-white granular deposits on the corneas, which can lead to complete loss of sight. While ACD usually develops slowly, carriers of this genetic mutation are at an extremely high risk of experiencing diminished vision and eventual blindness should they undergo vision-correction refractive surgery such as LASIK, LASEK or PRK. Fortunately, the AGDS Test positively identifies with 100 percent accuracy if a person has the genetic mutation. By doing so, the test reduces the risk of patients with ACD having post-LASIK vision impairment or blindness and increases their confidence that they are avoiding unnecessary harm to their vision. 

"We pride ourselves in offering our patients the latest technologies to make vision correction surgery even safer for our patients," said Dr. Tom Tooma , founder of NVISION Laser Eye Centers. "Offering the AGDS Test differentiates NVISION by adding a level of safety to the LASIK procedure that other laser eye centers cannot offer. We are very excited to be the first provider in the country and the only one in southern California to offer the AGDS Test."

The AGDS Test is easy and safe, involving just a simple mouth swab from a patient's cheek. The sample is then sent to Avellino Lab USA's certified molecular diagnostic testing lab. Within 24 to 48 hours, the results are provided to the NVISION physician to share with the patient. Based on a negative result, patients are able to proceed with the planned LASIK procedure with confidence. If an individual is identified as positive for the genetic mutation, he or she will be advised against having LASIK surgery and encouraged to take protective measures, such as minimizing exposure to UV light by wearing appropriate protective lenses, to help postpone the progression of ACD symptoms.

"NVISION's offering of the AGDS Test demonstrates their commitment to providing patients with the most innovative and state-of-the-art care," said Scott Korney , chief operating officer of Avellino Lab USA. "We are proud to work with NVISION in advancing our efforts to make LASIK safer for the thousands of patients who undergo eye vision correction surgery each year."

About Avellino Lab USA
Avellino Lab USA has developed the first and only commercially available testing system for Avellino Corneal Dystrophy (ACD), also known as Granular Corneal Dystrophy type 2. The company's advanced genetic diagnostics system provides fast, safe and affordable evaluations of an individual's genetic predisposition to ACD. Known as the Avellino-GENE Detection System (AGDS™) Test, Avellino Lab USA is able to positively identify, with 100 percent accuracy, a patient's ACD status. Based on the test's results, patients and their physician can make an informed decision when considering vision correction surgery.

About NVISION Laser Eye Centers
NVISION Laser Eye Centers now has 17 locations throughout California. NVISION Laser Eye Centers is the first provider in California to offer LASIK eye surgery with the Swiss-engineered Ziemer Femto LDVD Crystal Line™ Laser -- the highest level of laser vision correction available today. NVISION is also the first provider in California to offer the bladeless, computer-controlled LenSx laser, unquestionably the most technologically advanced option for laser cataract surgery.

With more than 1,400 eye doctors who refer their patients and trust their own eyes to NVISION surgeons, NVISION Laser Eye Centers is the Eye Doctors' #1 Choice.

For more information, call 1-877-91NVISION (1-877-916-8474).


'/>"/>
SOURCE Avellino Lab USA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Envisioning the Future: Hospitals Fully Integrated with Medical Device Connectivity Solutions
2. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
3. Pinnacle Biologics and INTERmedic Medical Devices announce strategic manufacturing and distribution agreement for cancer laser technology
4. Block Engineering Partners with SKAE and Pembroke for Quantum Cascade Laser Instrument Sales
5. Surgeon-Operated Palm Beach Tattoo Removal Clinic Incorporates Astanza Duality Laser Technology
6. Dr. TATTOFF Announces Use of Astanza Laser Tattoo Removal Systems for New Phoenix Location
7. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
8. Pinnacle Biologics acquires PDT laser technology
9. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
10. Dental Lasers Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
11. Cogmedix Expands To Support Laser Based Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017   Royal ... leader in health technology, and PathAI, a company ... collaborating with the aim to develop solutions that ... of cancer and other diseases. The partnership aims ... enabling this form of artificial intelligence to be ...
(Date:3/29/2017)... 29, 2017 Neurim Pharmaceuticals ("Neurim") ... obtain exclusive marketing rights for Neurim,s new Rx PedPRM in ... ... treat sleep disorders in children with Autism Spectrum Disorders (ASD) and ... approved for children. The collaboration with Exeltis will help ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The global patient safety and risk management software market ... Patient safety has become a priority for almost ... significantly in the last decade and is currently on the verge ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... ... Immunotherapy has emerged as one of the most promising options for the ... next revolution in our fight against this complex disease. One of the most effective ... such as PD-1 and PD-L1 inhibitors. , While a few single analyte immunohistochemistry tests ...
(Date:3/29/2017)... ... ... AvePoint , the Microsoft Cloud expert, is pleased to announce the official ... Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ceremony on ... of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more than 1,400 ...
(Date:3/28/2017)... YORK (PRWEB) , ... March 28, 2017 , ... ... NTX Technology™, is the first technology to directly address the resolution to globally ... NTX Technology™ is a patented compound of FDA and TTB approved ingredients that ...
(Date:3/28/2017)... ... , ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts ... Secret. Dr. Wentz talked about journey and research recently on a blog and discussed ... the only solution to deal with thyroid disease. , Dr. Wentz completed her ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader ... Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the ... their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling ...
Breaking Medicine News(10 mins):